ANKRD7
Ankyrin repeat domain-containing protein 7
Also known as: ANKR7_HUMAN, TSA806
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92527
- Gene
- ANKRD7
- Ensembl
- ENSG00000106013
- Chromosome
- 7
- Canonical length
- 254 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to act upstream of or within blastocyst hatching. Located in centrosome and nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
254 residues, UniProt reviewed canonical sequence.
>Q92527|ANKRD7
1 MNKLFSFWKR KNETRSQGYN LREKDLKKLH RAASVGDLKK LKEYLQIKKY DVNMQDKKYR
61 TPLHLACANG HTDVVLFLIE QQCKINVRDS ENKSPLIKAV QCQNEDCATI LLNFGADPDL
121 RDIRYNTVLH YAVCGQSLSL VEKLLEYEAD LEAKNKDGYT PLLVAVINNN PKMVKFLLEK
181 GADVNASDNY QRTALILAVS GEPPCLVKLL LQQGVELCYE GIVDSQLRNM FISMVLLHRY
241 PQFTASHGKK KHAKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ANKRD7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 804 nTPM
Expression across tissuesHPA
Tissue
- testis: 804 nTPM
- epididymis: 1.8 nTPM
- thyroid gland: 0.8 nTPM
- kidney: 0.7 nTPM
- pancreas: 0.6 nTPM
- pituitary gland: 0.6 nTPM
Single-cell type
- late primary spermatocytes: 7,265 nCPM
- early spermatids: 2,845 nCPM
- early primary spermatocytes: 1,159 nCPM
- late spermatids: 914 nCPM
- sertoli cells: 173 nCPM
- other brain neurons: 89 nCPM
Immune cell
- memory B-cell: 0.9 nTPM
- eosinophil: 0.2 nTPM
- memory CD8 T-cell: 0.1 nTPM
- naive CD8 T-cell: 0.1 nTPM
- plasmacytoid DC: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- pons: 4.9 nTPM
- hypothalamus: 4.8 nTPM
- thalamus: 4.3 nTPM
- cerebral cortex: 4.2 nTPM
- midbrain: 4.2 nTPM
- medulla oblongata: 4.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.23
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.97
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ANKRD7 as an antibody target. Whether an autoantibody or antibody against ANKRD7 could matter depends on whether native ANKRD7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ANKRD7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ANKRD7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...